Both in Pharmaceuticals
Johnson & Johnson vs Abbott Laboratories
Over the past year JNJ returned +49.7% and ABT returned −24.1%; their daily moves had a correlation of 0.31.
JNJ +49.7% ABT −24.1%Growth of $1, one year, split-adjusted
| Metric | JNJ | ABT |
|---|---|---|
| Price | $271.95 | $100.98 |
| Market cap | $655.37B | $174.73B |
| Today | +0.27% | −0.31% |
| 1 month | +2.3% | −9.5% |
| 6 months | +13.1% | −2.9% |
| Year to date | +31.4% | −19.4% |
| 1 year | +53.0% | −24.3% |
| Revenue growth (YoY) | +6.6% | +13.0% |
| Gross margin | 68.2% | 57.7% |
| Net margin | 21.9% | 7.4% |
| P/E (TTM) | 31.2× | 32.2× |
| Price / sales | 6.7× | 3.8× |
| Net cash | -$28.28B | -$27.00B |
| Dividend yield | 1.97% | 2.50% |
| Volatility (60d) | 20.7% | 29.9% |
| Short % of float | 0.9% | 1.2% |
| Next earnings | Oct 13, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).